Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial

BackgroundThe majority of patients using antihypertensive medications fail to achieve their recommended target blood pressure. Poor daily adherence with medication regimens and a lack of persistence with medication use are two of the major reasons for failure to reach target blood pressure. There is...

Full description

Bibliographic Details
Main Authors: Lau, R., Stewart, K., McNamara, K., Jackson, S., Hughes, Jeffery, Peterson, G., Bortoletto, D., McDowell, J., Bailey, M., Hsueh, A., George, J.
Format: Journal Article
Published: BioMed Central 2010
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/48172
_version_ 1848758036856832000
author Lau, R.
Stewart, K.
McNamara, K.
Jackson, S.
Hughes, Jeffery
Peterson, G.
Bortoletto, D.
McDowell, J.
Bailey, M.
Hsueh, A.
George, J.
author_facet Lau, R.
Stewart, K.
McNamara, K.
Jackson, S.
Hughes, Jeffery
Peterson, G.
Bortoletto, D.
McDowell, J.
Bailey, M.
Hsueh, A.
George, J.
author_sort Lau, R.
building Curtin Institutional Repository
collection Online Access
description BackgroundThe majority of patients using antihypertensive medications fail to achieve their recommended target blood pressure. Poor daily adherence with medication regimens and a lack of persistence with medication use are two of the major reasons for failure to reach target blood pressure. There is no single intervention to improve adherence with antihypertensives that is consistently effective. Community pharmacists are in an ideal position to promote adherence to chronic medications. This study aims to test a specific intervention package that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications - Hypertension Adherence Program in Pharmacy (HAPPY).Methods/DesignThe HAPPY trial is a multi-centre prospective randomised controlled trial. Fifty-six pharmacies have been recruited from three Australian states. To identify potential patients, a software application (MedeMine CVD) extracted data from a community pharmacy dispensing software system (FRED Dispense). The pharmacies have been randomised to either 'Pharmacist Care Group' (PCG) or 'Usual Care Group' (UCG). To check for 'Hawthorne effect' in the UCG, a third group of patients 'Hidden Control Group' (HCG) will be identified in the UCG pharmacies, which will be made known to the pharmacists at the end of six months. Each study group requires 182 patients. Data will be collected at baseline, three and six months in the PCG and at baseline and six months in the UCG. Changes in patient adherence and persistence at the end of six months will be measured using the self-reported Morisky score, the Tool for Adherence Behaviour Screening and medication refill data.DiscussionTo our knowledge, this is the first research testing a comprehensive package of evidence-based interventions that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications. The unique features of the HAPPY trial include the use of MedeMine CVD to identify patients who could potentially benefit from the service, control for the 'Hawthorne effect' in the UCG and the offer of the intervention package at the end of six months to patients in the UCG, a strategy that is expected to improve retention.Trial RegistrationAustralian New Zealand Clinical Trial Registry ACTRN12609000705280
first_indexed 2025-11-14T09:37:36Z
format Journal Article
id curtin-20.500.11937-48172
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:37:36Z
publishDate 2010
publisher BioMed Central
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-481722017-09-13T16:01:01Z Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial Lau, R. Stewart, K. McNamara, K. Jackson, S. Hughes, Jeffery Peterson, G. Bortoletto, D. McDowell, J. Bailey, M. Hsueh, A. George, J. pharmacy antihypertensives hypertension BackgroundThe majority of patients using antihypertensive medications fail to achieve their recommended target blood pressure. Poor daily adherence with medication regimens and a lack of persistence with medication use are two of the major reasons for failure to reach target blood pressure. There is no single intervention to improve adherence with antihypertensives that is consistently effective. Community pharmacists are in an ideal position to promote adherence to chronic medications. This study aims to test a specific intervention package that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications - Hypertension Adherence Program in Pharmacy (HAPPY).Methods/DesignThe HAPPY trial is a multi-centre prospective randomised controlled trial. Fifty-six pharmacies have been recruited from three Australian states. To identify potential patients, a software application (MedeMine CVD) extracted data from a community pharmacy dispensing software system (FRED Dispense). The pharmacies have been randomised to either 'Pharmacist Care Group' (PCG) or 'Usual Care Group' (UCG). To check for 'Hawthorne effect' in the UCG, a third group of patients 'Hidden Control Group' (HCG) will be identified in the UCG pharmacies, which will be made known to the pharmacists at the end of six months. Each study group requires 182 patients. Data will be collected at baseline, three and six months in the PCG and at baseline and six months in the UCG. Changes in patient adherence and persistence at the end of six months will be measured using the self-reported Morisky score, the Tool for Adherence Behaviour Screening and medication refill data.DiscussionTo our knowledge, this is the first research testing a comprehensive package of evidence-based interventions that could be integrated into the community pharmacy workflow to enable pharmacists to improve patient adherence and/or persistence with antihypertensive medications. The unique features of the HAPPY trial include the use of MedeMine CVD to identify patients who could potentially benefit from the service, control for the 'Hawthorne effect' in the UCG and the offer of the intervention package at the end of six months to patients in the UCG, a strategy that is expected to improve retention.Trial RegistrationAustralian New Zealand Clinical Trial Registry ACTRN12609000705280 2010 Journal Article http://hdl.handle.net/20.500.11937/48172 10.1186/1472-6963-10-34 BioMed Central fulltext
spellingShingle pharmacy
antihypertensives
hypertension
Lau, R.
Stewart, K.
McNamara, K.
Jackson, S.
Hughes, Jeffery
Peterson, G.
Bortoletto, D.
McDowell, J.
Bailey, M.
Hsueh, A.
George, J.
Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title_full Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title_fullStr Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title_full_unstemmed Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title_short Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
title_sort evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
topic pharmacy
antihypertensives
hypertension
url http://hdl.handle.net/20.500.11937/48172